Company Filing History:
5 out of 31 
1 out of 2 
1 out of 1,777 
Years Active: 2012-2023
Title: Innovations of Kim Birkebaek Jensen
Introduction
Kim Birkebaek Jensen is a notable inventor based in Roedovre, Denmark. He has made significant contributions to the field of chemistry, particularly in the development of novel acylating agents and methods for synthesizing bifunctional complexes. With a total of 7 patents to his name, Jensen's work has implications in pharmaceutical applications.
Latest Patents
One of Jensen's latest patents is titled "DCHBS-active esters of PEG compounds and their use." This invention relates to a novel acylating agent, which is a compound designed to acylate amino groups of amino acids, peptides, or proteins. The acylating agent features a structural element that enhances its stability and improves the acylation process, leading to better yield and production economy. This agent is particularly useful for acylating pharmaceutical peptides and proteins such as GLP-1, insulin, pYY, and amylin. Another significant patent involves a method for obtaining a bifunctional complex that includes a display molecule part and a coding part, which is essential for various biochemical applications.
Career Highlights
Throughout his career, Kim Birkebaek Jensen has worked with companies such as Nuevolution A/S and Neuvolution A/S. His innovative approaches and research have positioned him as a key figure in the field of biochemistry and pharmaceutical development.
Collaborations
Jensen has collaborated with notable professionals in his field, including Per-Ola Freskgard and Thomas Franch. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Kim Birkebaek Jensen's contributions to the field of chemistry and his innovative patents demonstrate his commitment to advancing pharmaceutical science. His work continues to influence the development of new therapeutic agents and methods.